Functional differences between two classes of oncogenic mutation in the PIK3CA gene
- 17 April 2009
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 381 (4), 577-581
- https://doi.org/10.1016/j.bbrc.2009.02.081
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibitionBiochemical Journal, 2008
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activityMolecular Cancer Therapeutics, 2008
- The regulation and function of Class III PI3Ks: novel roles for Vps34Biochemical Journal, 2008
- Evidence for functional redundancy of class IA PI3K isoforms in insulin signallingBiochemical Journal, 2007
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingCell, 2006
- Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase InhibitorJNCI Journal of the National Cancer Institute, 2006
- Mutation of the PIK3CA Gene in Ovarian and Breast CancerCancer Research, 2004
- High Frequency of Mutations of the PIK3CA Gene in Human CancersScience, 2004
- Phosphoinositide 3-kinase: the key switch mechanism in insulin signallingBiochemical Journal, 1998
- Phosphoinositide 3-kinase and the regulation of cell growthBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996